Skip to content
Reference draft · Awaiting editorial review
inside your peptides.
Search

The article archive

Make sense of
the bigger picture.

Browse 17 archive reports on research, testing, supply chains and policy. Publication dates stay visible so older reporting does not look like today's news.

Revised drafts, clearly labelled.

All 17 archive articles have revised language. Scientific and legal review remains pending. Research news has separately dated source updates.

Read the research news

August 2026 archive

Explore by question.

17 articles

Research · Archive

Lean mass is not the same as muscle

Why a scan result, hormone change and muscle-growth claim need different evidence.

Read the archive report
Research · Archive

Food noise: the phrase and the research

How a community phrase became a research question, and why appetite, craving and food preoccupation differ.

Read the archive report
Research · Archive

BPC-157 trials: funding incentives and unanswered questions

Why trial funding is complicated, and why a registry entry is neither a result nor a reason to predict no trial can happen.

Read the archive report
Policy · Archive

Peptides in sport: prohibition is not proof of benefit

Why an anti-doping ban, detection assay and treatment trial cannot substitute for one another.

Read the archive report
Research · Archive

How to read peptide community reports

A framework for reading sincere experiences without converting them into proof of effectiveness or safety.

Read the archive report
Research · Archive

Peptides in 2026: evidence and regulatory status

A dated field guide to compounds, evidence layers and the regulatory distinctions behind the headlines.

Read the archive report
Research · Archive

GHK-Cu: topical studies and route differences

Separate copper-peptide mechanisms, topical studies and untested route assumptions.

Read the archive report
Research · Archive

Skin claims: collagen, elastin and pores

Learn why visible changes, collagen measurements and functional elastic fibers are not interchangeable.

Read the archive report
Testing & COAs · Archive

The next lab documentation review: criteria and limits

A transparent case study of an affiliated supplier's paperwork, including the evidence needed to reproduce a score.

Read the archive report
Testing & COAs · Archive

How to read a peptide certificate of analysis

A practical checklist for checking the document, the tested sample and the limits of each result.

Read the archive report
The market · Archive

Peptide supply chains: what the documents show

Ask better questions about origin, finished-lot testing and claims that a supplier is registered.

Read the archive report
Research · Archive

Retatrutide: trial results and open questions

Put the older 24 percent headline beside the newer Phase 3 record, without treating either as product approval.

Read the archive report
Research · Archive

GLP-1 studies: what lean-mass loss means

Read the body-composition substudies without turning lean mass into a muscle-loss headline.

Read the archive report
The market · Archive

Peptide payments: declines and dispute rights

What a changing checkout can tell you, and what it cannot tell you about a supplier.

Read the archive report
Policy · Archive

Peptide regulation: approval, compounding and research labels

A guide to the different regulatory questions that are often collapsed into one headline.

Read the archive report
Research · Archive

BPC-157: what the evidence can establish

Separate animal findings, small human reports and trial registrations from proven treatment claims.

Read the archive report
Testing & COAs · Archive

Endotoxin, microbial screening and sterility

Understand three tests that are often sold under one badge, including what a negative result cannot promise.

Read the archive report